| scholarly article | Q13442814 |
| P2093 | author name string | Bin Wang | |
| Rui Zhang | |||
| Jing Xie | |||
| Ying Wu | |||
| Jin Jiang | |||
| Xuan Zhou | |||
| Zhi-Gang Li | |||
| Si-Dan Li | |||
| Yong-Bing Chen | |||
| Xiao-Li Ma | |||
| Hu-Yong Zheng | |||
| Rui-Dong Zhang | |||
| Min-Yuan Wu | |||
| Mao-Quan Qin | |||
| Run-Hui Wu | |||
| P2860 | cites work | [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)] | Q68183331 |
| Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995) | Q73462128 | ||
| Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients | Q74565166 | ||
| [Clinical study on childhood acute lymphoblastic leukemia diagnosed and treated with 04 Protocol in Chongqing, China] | Q83082702 | ||
| Death analysis of childhood acute lymphoblastic leukaemia; experience at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan | Q83147689 | ||
| [Report on induction efficacy of protocol ALL-2005 and middle term follow-up of 158 cases of childhood acute lymphoblastic leukemia] | Q84619278 | ||
| 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | Q34114674 | ||
| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america | Q34160380 | ||
| Biology, risk stratification, and therapy of pediatric acute leukemias: an update | Q34764504 | ||
| Childhood acute lymphoblastic leukemia: update on prognostic factors | Q37400956 | ||
| Results and significance of six randomized trials in four consecutive ALL-BFM studies | Q37913555 | ||
| Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia | Q39785801 | ||
| Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation | Q40274081 | ||
| Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia | Q40444406 | ||
| Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 | Q40547323 | ||
| Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits | Q40550138 | ||
| Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma--a rationale for tailored supportive care | Q40594200 | ||
| Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia | Q40847963 | ||
| Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study | Q43896325 | ||
| Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93 | Q44460712 | ||
| ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center. | Q52889397 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphoblastic leukemia | Q18553852 |
| P304 | page(s) | 472-476 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Chinese Medical Journal | Q5100534 |
| P1476 | title | Infections during induction therapy of protocol CCLG-2008 in childhood acute lymphoblastic leukemia: a single-center experience with 256 cases in China | |
| P478 | volume | 128 |
Search more.